Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12024746 Methods and systems for detecting genetic variants

Patent 12024746 was granted and assigned to Guardant Health on July, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Guardant Health
Guardant Health
0
Date Filed
December 11, 2023
0
Date of Patent
July 2, 2024
0
Patent Applicant
Guardant Health
Guardant Health
0
Patent Application Number
18535485
0
Patent Citations
‌
US Patent 7163789 Cancer diagnosis method
0
‌
US Patent 7208275 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
0
‌
US Patent 7406385 System and method for consensus-calling with per-base quality values for sample assemblies
0
‌
US Patent 7410764 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
0
‌
US Patent 7424368 Methods for identifying DNA copy number changes
0
‌
US Patent 7424371 Nucleic acid analysis
0
‌
US Patent 7537897 Molecular counting
0
‌
US Patent 7700286 Method for the detection of cancer
0
‌
US Patent 7704687 Digital karyotyping
0
‌
US Patent 7727720 Methods for detection of genetic disorders
0
•••
Patent Inventor Names
Stefanie Ann Ward Mortimer
0
AmirAli Talasaz
0
Helmy Eltoukhy
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12024746
0
Patent Primary Examiner
‌
Kenneth R Horlick
0
CPC Code
‌
C12Q 1/6869
0

Find more entities like US Patent 12024746 Methods and systems for detecting genetic variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.